These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 22430797)

  • 1. Increased DNA methyltransferase activity and DNA methylation following Epidermal Growth Factor stimulation in ovarian cancer cells.
    Samudio-Ruiz SL; Hudson LG
    Epigenetics; 2012 Mar; 7(3):216-24. PubMed ID: 22430797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contributions of the Epidermal Growth Factor Receptor to Acquisition of Platinum Resistance in Ovarian Cancer Cells.
    Granados ML; Hudson LG; Samudio-Ruiz SL
    PLoS One; 2015; 10(9):e0136893. PubMed ID: 26351843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TGF-β induces global changes in DNA methylation during the epithelial-to-mesenchymal transition in ovarian cancer cells.
    Cardenas H; Vieth E; Lee J; Segar M; Liu Y; Nephew KP; Matei D
    Epigenetics; 2014 Nov; 9(11):1461-72. PubMed ID: 25470663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Priming with EGFR tyrosine kinase inhibitor and EGF sensitizes ovarian cancer cells to respond to chemotherapeutical drugs.
    Cao C; Lu S; Sowa A; Kivlin R; Amaral A; Chu W; Yang H; Di W; Wan Y
    Cancer Lett; 2008 Aug; 266(2):249-62. PubMed ID: 18400375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alteration of DNA methylation status induced by epidermal growth factor in gastric cancer cell line, MKN-74.
    Saikawa Y; Kubota T; Otani Y; Kitajima M; Modlin IM
    Anticancer Res; 2003; 23(1A):143-8. PubMed ID: 12680205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of E-cadherin down-regulation in oral cancer: CDH1 gene expression and epigenetic blockage.
    Pannone G; Santoro A; Feola A; Bufo P; Papagerakis P; Lo Muzio L; Staibano S; Ionna F; Longo F; Franco R; Aquino G; Contaldo M; De Maria S; Serpico R; De Rosa A; Rubini C; Papagerakis S; Giovane A; Tombolini V; Giordano A; Caraglia M; Di Domenico M
    Curr Cancer Drug Targets; 2014; 14(2):115-27. PubMed ID: 24274398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cell surface glycoprotein CUB domain-containing protein 1 (CDCP1) contributes to epidermal growth factor receptor-mediated cell migration.
    Dong Y; He Y; de Boer L; Stack MS; Lumley JW; Clements JA; Hooper JD
    J Biol Chem; 2012 Mar; 287(13):9792-9803. PubMed ID: 22315226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined inhibition of epidermal growth factor receptor and JAK/STAT pathways results in greater growth inhibition in vitro than single agent therapy.
    Dowlati A; Nethery D; Kern JA
    Mol Cancer Ther; 2004 Apr; 3(4):459-63. PubMed ID: 15078989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gonadotropins upregulate the epidermal growth factor receptor through activation of mitogen-activated protein kinases and phosphatidyl-inositol-3-kinase in human ovarian surface epithelial cells.
    Choi JH; Choi KC; Auersperg N; Leung PC
    Endocr Relat Cancer; 2005 Jun; 12(2):407-21. PubMed ID: 15947112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inactivation of ADAMTS18 by aberrant promoter hypermethylation contribute to lung cancer progression.
    Zhang Y; Xu H; Mu J; Guo S; Ye L; Li D; Peng W; He X; Xiang T
    J Cell Physiol; 2019 May; 234(5):6965-6975. PubMed ID: 30417422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct monitoring of breast and endometrial cancer cell epigenetic response to DNA methyltransferase and histone deacetylase inhibitors.
    Teixeira SR; Abreu CM; Parkes L; Davies J; Yao S; Sawhney MA; Margarit L; Gonzalez D; Pinto IM; Francis LW; Conlan RS
    Biosens Bioelectron; 2019 Sep; 141():111386. PubMed ID: 31220725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. S-allylcysteine suppresses ovarian cancer cell proliferation by DNA methylation through DNMT1.
    Xu Y; Su D; Zhu L; Zhang S; Ma S; Wu K; Yuan Q; Lin N
    J Ovarian Res; 2018 May; 11(1):39. PubMed ID: 29759079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-Aza-2'-deoxycytidine induces a greater inflammatory change, at the molecular levels, in normoxic than hypoxic tumor microenvironment.
    Salviano Soares de Amorim Í; Rodrigues JA; Nicolau P; König S; Panis C; de Souza da Fonseca A; Mencalha AL
    Mol Biol Rep; 2021 Feb; 48(2):1161-1169. PubMed ID: 33547534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross talk of signals between EGFR and IL-6R through JAK2/STAT3 mediate epithelial-mesenchymal transition in ovarian carcinomas.
    Colomiere M; Ward AC; Riley C; Trenerry MK; Cameron-Smith D; Findlay J; Ackland L; Ahmed N
    Br J Cancer; 2009 Jan; 100(1):134-44. PubMed ID: 19088723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prognostic implication of alterations in epidermal growth factor receptor and MGMT in glioblastoma].
    Zhang LY; Ge HJ; Wang LM; Zhao LH; Liu L; Zhang DJ; Cai YN; Lu DH; Piao YS
    Zhonghua Bing Li Xue Za Zhi; 2019 Mar; 48(3):186-191. PubMed ID: 30831643
    [No Abstract]   [Full Text] [Related]  

  • 16. Matrix metalloproteinase 9 is a mediator of epidermal growth factor-dependent e-cadherin loss in ovarian carcinoma cells.
    Cowden Dahl KD; Symowicz J; Ning Y; Gutierrez E; Fishman DA; Adley BP; Stack MS; Hudson LG
    Cancer Res; 2008 Jun; 68(12):4606-13. PubMed ID: 18559505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of Rho-associated coiled-coil containing protein kinase enhances the activation of epidermal growth factor receptor in pancreatic cancer cells.
    Nakashima M; Adachi S; Yasuda I; Yamauchi T; Kawaguchi J; Hanamatsu T; Yoshioka T; Okano Y; Hirose Y; Kozawa O; Moriwaki H
    Mol Cancer; 2011 Jul; 10():79. PubMed ID: 21722395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA hypomethylation-mediated activation of Cancer/Testis Antigen 45 (CT45) genes is associated with disease progression and reduced survival in epithelial ovarian cancer.
    Zhang W; Barger CJ; Link PA; Mhawech-Fauceglia P; Miller A; Akers SN; Odunsi K; Karpf AR
    Epigenetics; 2015; 10(8):736-48. PubMed ID: 26098711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA methylation in ovarian cancer. II. Expression of DNA methyltransferases in ovarian cancer cell lines and normal ovarian epithelial cells.
    Ahluwalia A; Hurteau JA; Bigsby RM; Nephew KP
    Gynecol Oncol; 2001 Aug; 82(2):299-304. PubMed ID: 11531283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic inactivation of EGFR by CpG island hypermethylation in cancer.
    Montero AJ; Díaz-Montero CM; Mao L; Youssef EM; Estecio M; Shen L; Issa JP
    Cancer Biol Ther; 2006 Nov; 5(11):1494-501. PubMed ID: 17369752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.